NORMOMED® (Inosine pranobex, Imunovir, Delimmun, Isoprinosine) 500 mg/tab, 20-30-50 tabs/pack

NORMOMED® (Inosine pranobex, Imunovir, Delimmun, Isoprinosine) - is a combination of inosine, acetamidobenzoic acid and dimethylaminoisopropanol used as an antiviral drug. Works by slowing the growth and spread of the virus in the body. It may also stimulate the immune system in the body, which helps to increase the body's ability to fight these infections. Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II).

USES

• Treatment of Influenza and Other Acute Respiratory Viral Infections.
• Infections Caused by the Herpes Virus Types I and II.
• Genital and labial herpes, herpetic keratitis, chickenpox, shingles.
• Infectious moionucleosis caused by the Epstein-Barr virus.
• Cytomegalovirus infection.
• Sereve measles.
• Papillomavirus infection: papilloma of the larynx/vocal cords (fibrous type), papillomavirus infection of the genital organs in men and women, warts.
• Subacute sclerosing panencephalitis molluscum contagiosum.

GUARANTEE & EXPIRY DATE

100% original from Russian pharmaceutical company Obninskaya Khimiko-pharmaceutical Company.

All packs are air tight sealed and expire up to 08.2027.

Photos of the product are for illustation purpose only and may vary according to the manufacturer.

DESCRIPTION

Inosine pranobex (BAN also known as inosine acedoben dimepranol (INN) or methisoprinol) is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

PACKAGING

NORMOMED® comes in the form of tablets for oral use: 500 mg per tablet, 20 tablets per pack.

Active ingredient:

Inosine pranobex - 500 mg.



Excipients:

Microcrystalline cellulose - 33.5 mg, Psrlitol flash (mannitol - 80% and corn starch - 20%) - 33.5 mg, Carboxymethyl starch sodium - 67.0 mg, Povidone K-17 - 10.0 mg, Magnesium stearate - 6.0 mg.

DOSAGE

Orally, 20-30 minutes after meals with water, without chewing.

The recommended daily dose for adults and children aged 3 years and older (body weight over 15-20 kg) is 50 mg per 1 kg body weight in 3-4 doses, which is on average for adults - 6-8 tablets per day, for children - 1/2 tablet per 5 kg of body weight per day. In severe forms of infectious diseases, the dose can be individually increased up to 100 mg / kg body weight per day, divided into 4-6 doses. The maximum daily dose for adults is 3-4 g / day, for children aged 3 years and older - 50 mg / kg / day.

Duration of treatment:

In acute diseases, the duration of treatment in adults and children is usually 5-14 days. Treatment should be continued for 2 days after the disappearance of clinical symptoms. If necessary, the duration of treatment can be increased individually under the supervision of a physician.

In chronic relapsing diseases, treatment in adults and children is carried out in several courses lasting 5-10 days at intervals of 8 days. During maintenance therapy, the dose can be reduced to 500-1000 mg / day (1-2 tablets) for 30 days.

In cases of herpes infection, adults and children are prescribed for 5-10 days before the symptoms disappear, in the asymptomatic period, 1 tablet 2 times a day for 30 days to reduce the number of relapses.

PRECAUTIONS

• Hypersensitivity to inosine pranobex and other components of the drug.
• Gout.
• Urolithiasis disease.
• Chronic renal failure.
• Arrhythmias.
• Pregnancy and lactation.
• children's age up to 3 years (body weight up to 15-20 kg).
• Caution should be exercised while concomitant administration with xanthine oxidase inhibitors, diuretics, zidovudine, in acute liver failure.
• Use during pregnancy and the period of breastfeeding is contraindicated.

SIDE EFFECTS

The frequency of side effects after using the drug is classified according to WHO recommendations: frequent -> 1% and <10% infrequent -> 0.1% and <1%.

Nervous system: frequent - headache, dizziness, fatigue, poor health, weakness infrequent - nervousness, drowsiness, insomnia.

Gastrointestinal tract: frequent - decreased appetite, nausea, vomiting, epigastric pain infrequent - diarrhea, constipation.

Liver and biliary tract: frequent - a temporary increase in the activity of transaminases and alkaline phosphatase in blood plasma, an increase in the concentration of urea in blood plasma.

Kidneys and urinary tract: infrequent - polyuria.

General disorders: frequent - joint pain, exacerbation of gout.

STORAGE

Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.

QUESTIONS?

Ask us any questions about NORMOMED®.